About Farcast Biosciences
Farcast Biosciences is a Healthcare company based in Madison (United States) founded in 2009 by Pradip K Majumder, Padhma Radhakrishnan, and Shiladitya Sengupta. A system for preserving the tumor microenvironment is developed. Farcast Biosciences has raised $88.14 million across 5 funding rounds from investors including Tata Capital, Accel and RA Capital. The company has 30 employees. Its chief executive, as recorded, is Mohit Malhotra. Its Indian entity Farcast Biosciences India Private Limited reported revenue of ₹6.66 Cr. Farcast Biosciences offers products and services including TruTumor, TruPower, and Farcast Biodynamics System. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Biorepository.
Company details
Founded in 2009 and based in Madison, United States, the biotechnology firm specializes in anthropic biological systems, data, and an AI platform. Complexity of human tumors and autologous blood samples is captured through culturing that preserves the microenvironment, tumor architecture, and immune cell compartment. Ex vivo evaluations of tumor responses to drug treatments are enabled by these operations in the oncology sector.
- Headquarters Madison, United States
- Employees 30
- Founders Pradip K Majumder, Padhma Radhakrishnan, Shiladitya Sengupta
- SectorsHealthcare
- Website farcastbio.com
- Social LinkedIn
- Legal Name Farcast Biosciences India Private Limited
- Date of Incorporation 18 May, 2016
- Indian entity revenue₹6.66 Cr
FY 2022 · +102% YoY
- Indian entity net loss-₹1.01 Cr
FY 2022 · -15% margin
- Indian entity EBITDA-₹81.6 Lakh
FY 2022 · -12% margin
- Total Equity Funding$88.14M (USD)
in 5 rounds
- Latest Funding Round$43.82M (USD), Series C
Jul 2018
- InvestorsTata Capital
& 15 more
- Employee Count30
Associated legal entities of Farcast Biosciences
Farcast Biosciences operates through Farcast Biosciences India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Farcast Biosciences India Private Limited CIN U73100KA2016FTC093387 | Active | 18 May 2016 | Bangalore, Karnataka | ₹6.7 Cr | 30 | 3 | View details |
Products & Services of Farcast Biosciences
Farcast Biosciences offers a comprehensive portfolio of products and services, including TruTumor, TruPower, and Farcast Biodynamics System.
System for testing cancer therapies in preserved tumor contexts.
Platform for generating AI-driven predictive biosignatures.
Analyzes tumor data to forecast treatment responses accurately.
Funding Insights of Farcast Biosciences
Farcast Biosciences has successfully raised a total of $88.14M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $43.82 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $88.14M
- Total Rounds 5
- Last Round Series C — $43.82M
- First Round $6.77M
(Mar 2010)
- Investors Count 16
All 5 funding rounds of Farcast Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2018 | $43.82M | Series C | – | Northpond Ventures | |
| Aug 2016 | $27.4M | Series B | – | Sequoia Capital, Sands Capital Ventures | |
| Apr 2015 | $3.62M | Series B | – | Tata Capital | |
| Oct 2013 | $6.53M | Series B | – | Tata Capital | |
| Mar 2010 | $6.77M | Series A | – | Accel |
16 investors in total: 8 institutional and 8 angel.
Investors in Farcast Biosciences
Farcast Biosciences has secured backing from 16 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Tata Capital, Accel and RA Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in life sciences & tech sectors | npv.vc | Cambridge, United States | ||
Accel is recognized as a leading venture capital firm. | 1983 | accel.com | Palo Alto, United States | |
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | ||
Growth stage tech & life sciences focused VC Firm investing in Asia and the US | sandscapitalventures.com | Arlington, United States | ||
India focused early stage mivro VC firm | 2010 | indiainnovationfund.in | Bengaluru, India | |
Venture capital fund backed by government financial institutions focused on early and growth stage startups | 1999 | kitven.in | Bengaluru, India | |
RA Capital is engaged in evidence-based investing in healthcare and life sciences. | 2004 | racap.com | Boston, United States | |
Diversified non-banking financial services are provided by Tata Capital. | 2007 | tatacapital.com | Mumbai, India | |
RM Rajneesh Mehra | unknown_82f291a917ef403d8 | |||
RS Raj Sharma | Angel investor focusing on Indian startups in tech and consumer sectors. | unknown_4a28e090bd034df2b |
Investor details for Farcast Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Farcast Biosciences India Private Limited (Farcast Biosciences)
Farcast Biosciences India Private Limited is the primary company behind Farcast Biosciences. The board of Farcast Biosciences India Private Limited currently have 2 directors; the longest-serving is Mohit Malhotra, appointed in 2020. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mohit Malhotra DIN 03061163 | Director | 28 May 2020 | 6 yrs 5 mo | Farcast Biosciences India Private Limited |
| Satish Sankaran DIN 08750304 | Director | 30 May 2020 | 6 yrs 5 mo | Farcast Biosciences India Private Limited |
People of Farcast Biosciences
5 people are tracked at Farcast Biosciences (5 in leadership); the tracked headcount is 30.
| Name | Role | Group |
|---|---|---|
Pradip K Majumder | Co-Founder | Leadership |
Padhma Radhakrishnan | Co-Founder | Leadership |
Shiladitya Sengupta | Co-Founder | Leadership |
| CEO | Leadership | |
Maneesh Arora | CEO | Leadership |
Complete people profiles for Farcast Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Farcast Biosciences
Figures of Farcast Biosciences India Private Limited, the primary company behind Farcast Biosciences, for FY 2022. Revenue was ₹6.66 Cr (+102% year on year). Net loss was -₹1.01 Cr (-15% margin). EBITDA was -₹81.6 Lakh (-12% margin). Revenue has grown at a compounded annual rate of -37% over three years and +34% over five years.
- ₹6.66 CrRevenue · FY 2022 · +102% YoY
- -₹1.01 CrNet loss · -15% margin
- -₹81.6 LakhEBITDA · -12% margin
- ₹31.00 CrPaid-up capital
- 30Employees (provident fund records)
- -37%Revenue CAGR, 3 years
- +34%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Farcast Biosciences India Private Limited are on its company page.
Detailed financial statements for Farcast Biosciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Farcast Biosciences
3 dated milestones of Farcast Biosciences across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Farcast Biosciences is founded.
- Funding First funding round of $6.8M.
- Funding Latest funding round, Series C, of $43.8M.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Farcast Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Farcast Biosciences
Complete news archive for Farcast Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Farcast Biosciences
Farcast Biosciences was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Farcast Biosciences is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Mohit Malhotra is the CEO of Farcast Biosciences, as recorded in our data.
Farcast Biosciences is a funded company, having raised a total of $88.14M across 5 funding rounds to date. The company's 1st funding round was a Series A of $6.77M, raised on Mar 2010.
Farcast Biosciences has 30 employees.
The primary company behind Farcast Biosciences, Farcast Biosciences India Private Limited, reported revenue of ₹6.66 Cr for FY 2022, up 102% year on year.
Founded in 2009 and based in Madison, United States, the biotechnology firm specializes in anthropic biological systems, data, and an AI platform. Complexity of human tumors and autologous blood samples is captured through culturing that preserves the microenvironment, tumor architecture, and immune cell compartment. Ex vivo evaluations of tumor responses to drug treatments are enabled by these operations in the oncology sector.
Farcast Biosciences offers TruTumor, TruPower, and Farcast Biodynamics System.
Farcast Biosciences has 16 investors. Key investors include Tata Capital, Accel, RA Capital, KITVEN, and India Innovation Fund.
Farcast Biosciences operates through Farcast Biosciences India Private Limited.
The legal entities of Farcast Biosciences currently have 3 directors, including Satish Sankaran, Poornima Vishwanath Hegade, Mohit Malhotra.